Toxicity following Stereotactic Body Radiotherapy for Prostate Cancer in Patients with Inflammatory Bowel Disease: A Multi-Institutional Matched Case Control Series

To evaluate the safety of stereotactic body radiation therapy (SBRT) for prostate cancer in men with inflammatory bowel disease (IBD).We queried a consortium database for patients with IBD receiving SBRT for prostate cancer between 2006 and 2012. Identified patients were matched with patients without a history of IBD in a 3:1 fashion based on dose, fractionation, use of androgen deprivation therapy, and age distribution. Logistic regression was...